Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.50
-0.46 (-7.72%)
At close: Apr 28, 2026, 4:00 PM EDT
5.45
-0.05 (-0.91%)
After-hours: Apr 28, 2026, 7:31 PM EDT
Personalis Employees
As of December 31, 2025, Personalis had 260 total employees, including 259 full-time and 1 part-time employees. The number of employees increased by 31 or 13.54% compared to the previous year.
Employees
260
Change (1Y)
31
Growth (1Y)
13.54%
Revenue / Employee
$267,877
Profits / Employee
-$312,577
Market Cap
575.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| Castle Biosciences | 883 |
| CareDx | 765 |
PSNL News
- 5 days ago - Personalis to Announce First Quarter 2026 Financial Results - Business Wire
- 7 days ago - Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 - Business Wire
- 15 days ago - Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026 - Business Wire
- 27 days ago - Personalis to Participate in the 25th Annual Needham Virtual Conference - Business Wire
- 6 weeks ago - Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption - Business Wire
- 6 weeks ago - Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire
- 2 months ago - Personalis Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - Business Wire